Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

Saved in:

Bibliographic Details
Main Authors:	Elisabetta Benedetti, Renato Galzio, Barbara D’Angelo, Maria Paola Cerù, Annamaria Cimini
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2019/4309068
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors
by: Elisabetta Benedetti, et al.
Published: (2010-01-01)

Complex Form Variant of Dysembryoplastic Neuroepithelial Tumor of the Cerebellum
by: Jesús Vaquero, et al.
Published: (2012-01-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
by: Rolf Müller, et al.
Published: (2008-01-01)

The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products
by: Mario Umberto Dianzani, et al.
Published: (2008-01-01)

PPARs and Xenobiotic-Induced Adverse Effects: Relevance to Human Health
by: Christopher Lau, et al.
Published: (2010-01-01)

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
by: Graham Skelhorne-Gross, et al.
Published: (2012-01-01)

Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARγ and Identification of TUSC5 Coding Variants in Lean and Obese Humans
by: Trina A. Knotts, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors
by: Lars Tatenhorst, et al.
Published: (2008-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

PPARs in Neuroinflammation
by: Paul D. Drew, et al.
Published: (2008-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPARs and Metabolic Syndrome
by: Lihong Chen, et al.
Published: (2014-01-01)

PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy
by: Chantal Donovan, et al.
Published: (2012-01-01)

Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
by: Kira Vordermark, et al.
Published: (2024-12-01)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
by: Adrienne Bolden, et al.
Published: (2012-01-01)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
by: Neerupma Silswal, et al.
Published: (2012-01-01)

The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells
by: Jordan Clark, et al.
Published: (2009-01-01)

The Role of PPARs in Lung Fibrosis
by: Heather F. Lakatos, et al.
Published: (2007-01-01)

PPARs in Eye Biology and Disease
by: Suofu Qin, et al.
Published: (2008-01-01)

The Functions of PPARs in Aging and Longevity
by: Adnan Erol
Published: (2007-01-01)

PPARs in Alveolar Macrophage Biology
by: Monica R. Smith, et al.
Published: (2007-01-01)

PPAR-δ in Vascular Pathophysiology
by: Nanping Wang
Published: (2008-01-01)

PPARs and Adipose Cell Plasticity
by: Mamen Carmona, et al.
Published: (2007-01-01)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
by: Wojciech G. Garbacz, et al.
Published: (2015-01-01)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01)

Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines
by: G. Martinasso, et al.
Published: (2007-01-01)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
by: Zhongxia Wang, et al.
Published: (2019-01-01)

PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Nutrigenomic Functions of PPARs in Obesogenic Environments
by: Soonkyu Chung, et al.
Published: (2016-01-01)

Coactivators in PPAR-Regulated Gene Expression
by: Navin Viswakarma, et al.
Published: (2010-01-01)

The Role of PPAR Gamma in Systemic Sclerosis
by: Andréa Tavares Dantas, et al.
Published: (2015-01-01)

PPARs: Protectors or Opponents of Myocardial Function?
by: Christine J. Pol, et al.
Published: (2015-01-01)

PPARs in Irradiation-Induced Gastrointestinal Toxicity
by: Christine Linard, et al.
Published: (2010-01-01)

Regulatory role of PPAR in colorectal cancer
by: Cong Wang, et al.
Published: (2025-01-01)

Combined Effects of PPARγ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells
by: Katherine Pegg, et al.
Published: (2013-01-01)

2D-QSAR Analysis of Oxadiazole Substituted α-Isopropoxy phenylpropionic Acids as PPAR-α & PPAR-λ Agonists
by: Soni L. K., et al.
Published: (2004-01-01)

15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
by: Jingjing Li, et al.
Published: (2019-01-01)